Literature DB >> 9468634

Na(+)-glucose cotransporter inhibitors as antidiabetic agents. II. Synthesis and structure-activity relationships of 4'-dehydroxyphlorizin derivatives.

M Hongu1, T Tanaka, N Funami, K Saito, K Arakawa, M Matsumoto, K Tsujihara.   

Abstract

A novel series of 4'-dehydroxyphlorizin derivatives was synthesized and the effects of these compounds on urinary glucose excretion were evaluated in rats. There was a strict structural requirement for activity. Introduction of a small substituent or a flat ring at the 3- and/or the 4-position on the A ring was permissible, but any change at the bridge part between the A and B rings or in the sugar moiety resulted in complete loss of activity. The 6'-OH group on the B ring was also necessary, and even small structural modifications of the 6'-OH group reduced the activity considerably. Among the compounds synthesized, the 5-benzofuryl derivative 25 was the most potent and was selected as a new lead for further structure-activity relationship investigations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468634     DOI: 10.1248/cpb.46.22

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class.

Authors:  Paula Nogueira da Silva; Raissa Alves da Conceição; Rodolfo do Couto Maia; Maria Leticia de Castro Barbosa
Journal:  Medchemcomm       Date:  2018-06-06       Impact factor: 3.597

3.  A 96-well automated method to study inhibitors of human sodium-dependent D-glucose transport.

Authors:  Francisco Castaneda; Rolf K-H Kinne
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

4.  Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes.

Authors:  Francisco Castaneda; Antje Burse; Wilhelm Boland; Rolf K-H Kinne
Journal:  Int J Med Sci       Date:  2007-05-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.